India  

Microdose Chocolate May Cause Seizures, FDA Warns

Video Credit: Wibbitz Top Stories - Duration: 01:30s - Published
Microdose Chocolate May Cause Seizures, FDA Warns

Microdose Chocolate May Cause Seizures, FDA Warns

Microdose Chocolate , May Cause Seizures, FDA Warns.

The FDA says that several people in four states have gotten sick after eating Diamond Shruumz chocolate bars.

Severe symptoms experienced by the victims include "seizures, central nervous system depression, agitation, abnormal heart rates, hyper/hypotension, nausea and vomiting," CBS News reports.

.

The chocolate, which is sold across the country, landed six of the eight victims in the hospital.

.

The company's website says that the chocolate is manufactured with a "primo proprietary blend of nootropic and functional mushrooms.".

In 2022, the FDA called nootropics "a term widely used to market unapproved products as 'smart drugs' and 'cognitive enhancers.'".

On June 7, the FDA warned parents to keep their kids away from the chocolate which is marketed as candy.

.

Parents and caregivers should consider discussing the information in this advisory with their children and take extra care to avoid this product being consumed by younger people.

, FDA, via statement.

Half of the victims were in Arizona, CBS News reports.

.

While these products claim to contain only natural ingredients and no scheduled drugs, there is clearly something toxic occurring, Steve Dudley, director of the Arizona Poison and Drug Information Center, via news release.

We've seen the same phenomenon of people eating the chocolate bar then seizing, losing consciousness, and having to be intubated, Steve Dudley, director of the Arizona Poison and Drug Information Center, via news release


You Might Like


💡 newsR Knowledge: Other News Mentions

Food and Drug Administration Food and Drug Administration United States federal agency

Supreme Court Upholds FDA Regulation on Popular Abortion Drug Mifepristone [Video]

Supreme Court Upholds FDA Regulation on Popular Abortion Drug Mifepristone

Supreme Court Upholds , FDA Regulation on Popular , Abortion Drug Mifepristone. On June 13, the Supreme Court ruled against a group of doctors who challenged the Food and Drug Administration's (FDA) regulations on the abortion pill mifepristone. CBS reports that the case once again highlighted abortion access following the conservative majority decision to overturn Roe v. Wade in 2022. The court ruled unanimously that the group of anti-abortion rights doctors and medical associations lacked the legal right to challenge the FDA. . However, the court also did not address whether the FDA's decision to relax the rules for mifepristone's use were lawful. . The latest ruling was authored by Justice Brett Kavanaugh. . Under Article III of the Constitution, a plaintiff's desire to make a drug less available for others does not establish standing to sue. , Justice Brett Kavanaugh writing for the court, via CBS. Nor do the plaintiffs' other standing theories suffice. Therefore, the plaintiffs lack standing to challenge FDA's actions, Justice Brett Kavanaugh writing for the court, via CBS. CBS reports that the ruling does not impact other challenges to the FDA's standing on mifepristone, while preserving access to the popular abortion medication. In 2016 and 2021, the FDA took steps to widen access to mifepristone, which has been taken by over 5 million patients since first being approved in 2000. Those steps included allowing the drug to be taken up to 10 weeks into a pregnancy, reducing the number of in-person doctor visits and permitting it to be sold through the mail.

Credit: Wibbitz Top Stories    Duration: 01:30Published
FDA Reverses Ban on Juul E-Cigarettes [Video]

FDA Reverses Ban on Juul E-Cigarettes

FDA Reverses Ban , on Juul E-Cigarettes. On June 6, the Food and Drug Administration announced that it has reversed its ban on Juul e-cigarettes while the agency reviews new information. On June 6, the Food and Drug Administration announced that it has reversed its ban on Juul e-cigarettes while the agency reviews new information. NBC reports that the FDA first ordered Juul to take its product off the market in 2022, however the e-cigarettes have remained on shelves pending the company's appeal. NBC reports that the FDA first ordered Juul to take its product off the market in 2022, however the e-cigarettes have remained on shelves pending the company's appeal. In that time, Juul has maintained its position as the second-most popular e-cigarette in the U.S. The FDA noted that reversing the ban temporarily was not an indication that the company's product would be ultimately cleared. . The FDA noted that reversing the ban temporarily was not an indication that the company's product would be ultimately cleared. . Sales of alternative nicotine products, like e-cigarettes, have continued to grow in the past decade. . In 2023, the Centers for Disease Control and Prevention reported that e-cigarette use had grown by almost 50% between 2020 and 2022. . In 2023, the Centers for Disease Control and Prevention reported that e-cigarette use had grown by almost 50% between 2020 and 2022. . Juul released a statement following the FDA reversal, . ... saying the company looks forward to "re-engaging with the agency on a science- and evidence-based process to pursue a marketing authorization.". We remain confident in the quality and substance of our applications and believe that a full review of the science and evidence will demonstrate that our products meet the statutory standard of being appropriate for the protection of public health, Juul statement, via NBC. We remain confident in the quality and substance of our applications and believe that a full review of the science and evidence will demonstrate that our products meet the statutory standard of being appropriate for the protection of public health, Juul statement, via NBC. 'The Wall Street Journal' reports that Juul has argued that the 2022 ban significantly disrupted the company's finances, resulting in an investor bailout. Currently, the FDA has only granted approval for 23 e-cigarette products, manufactured by only three companies, to be marketed and sold to consumers

Credit: Wibbitz Top Stories    Duration: 01:31Published
FDA Reviewing Data on MDMA for Potential Approval of Groundbreaking PTSD Treatment [Video]

FDA Reviewing Data on MDMA for Potential Approval of Groundbreaking PTSD Treatment

FDA Reviewing Data on MDMA , for Potential Approval of , Groundbreaking PTSD Treatment. 'The Independent' reports that federal health advisers are considering a first-ever approval of MDMA, a psychedelic drug, to treat post traumatic stress disorder (PTSD). 'The Independent' reports that federal health advisers are considering a first-ever approval of MDMA, a psychedelic drug, to treat post traumatic stress disorder (PTSD). The news comes after decades of psychedelic advocates urging regulators to give the drug medical acceptance. . On June 4, the Food and Drug Administration (FDA) called on a group of outside experts to review the latest MDMA research. . The research suggests that when the drug is paired with talk therapy, it can help alleviate PTSD. . However, regulators at the FDA have questioned the reliability of the data, as well as the potential safety risks, which include possible heart problems and addiction. FDA approval could open the door for federal approval to be granted as soon as this summer. . Approval would make MDMA, often referred to as ecstasy or molly, the first illegal psychedelic to receive approval for mainstream medicine. . 'The Independent' reports that a number of psychedelics are expected to receive FDA reviews in the coming years amid interest in their potential to treat depression, anxiety and addiction. 'The Independent' reports that a number of psychedelics are expected to receive FDA reviews in the coming years amid interest in their potential to treat depression, anxiety and addiction. It’s clear that MDMA-assisted therapy would be a welcome addition to the currently available options, Dr. Kelley O'Donnell, a New York University psychiatrist who helped conduct the MDMA studies, via 'The Independent'. I’ve seen firsthand how this treatment can be lifesaving for some, Dr. Kelley O'Donnell, a New York University psychiatrist who helped conduct the MDMA studies, via 'The Independent'

Credit: Wibbitz Top Stories    Duration: 01:30Published
Cucumbers Are Recalled in 14 States [Video]

Cucumbers Are Recalled in 14 States

Cucumbers Are Recalled , in 14 States. Fresh Start Produce Sales in Florida is recalling cucumbers over possible salmonella contamination, 'Newsweek' reports. The 14 states affected by the recall include Alabama, Florida, Georgia, Illinois, Maryland, North Carolina, New Jersey, New York, Ohio, Pennsylvania, South Carolina, Tennessee, Virginia and West Virginia. Only large, whole cucumbers are included in the recall. Mini and English cucumbers are considered safe to eat. The Pennsylvania Department of Agriculture first informed Fresh Start that its product tested positive for salmonella. The FDA is conducting whole genome sequencing to determine if this sample is related to an ongoing salmonella outbreak investigation, Via recall notice. Fresh Start believes it recalled the product before it could make it into consumers' hands. Although these cucumbers are unlikely [to be found] in the marketplace, anyone with the recalled product should not consume it and should destroy and discard it or return it to the place of purchase for a refund, Fresh Start Produce Sales, via statement. Consumers should check with their retailer or place of purchase to determine whether the recalled cucumbers were sold where they shop, Fresh Start Produce Sales, via statement

Credit: Wibbitz Top Stories    Duration: 01:31Published

Arizona Arizona U.S. state

US presidential elections: The college freshman hoping to turn Arizona red [Video]

US presidential elections: The college freshman hoping to turn Arizona red

Credit: FRANCE 24 English    Duration: 02:12Published
Border Arrests Fall Over 40% Since Biden Suspended Asylum Processing [Video]

Border Arrests Fall Over 40% Since Biden Suspended Asylum Processing

Border Arrests Fall Over 40% , Since Biden Suspended Asylum Processing. The Homeland Security Department made the announcement on June 26, NPR reports. . Average daily arrests that the Border Patrol has made over a week-long period have dropped below 2,400. That is a decrease of over 40% from before the president's proclamation went into effect on June 5. That is a decrease of over 40% from before the president's proclamation went into effect on June 5. However, arrests need to drop to the 1,500 mark before asylum processing can resume. Still, the current data marks the lowest number of arrests since Jan. 17, 2021, NPR reports. . Last week, President Biden touted a 25% decrease in border arrests since the order took effect, . which means they've dropped a lot more since then. Homeland Security Secretary Alejandro Mayorkas has called the executive order a "tremendous success.". We indeed have seen a tremendous success early on, and I should emphasize that it is early on in our implementation of the president’s proclamation and our accompanying regulation, Alejandro Mayorkas, to CNN. Mayorkas will address border enforcement efforts in Tuscon, Arizona, on June 26. The area has served as "the busiest corridor for illegal crossings" recently, NPR reports.

Credit: Wibbitz Top Stories    Duration: 01:31Published